Evidence map›Paper›PMID 28870505›Full record

ArticleJournal of molecular and cellular cardiology2017

TGF-β1 affects cell-cell adhesion in the heart in an NCAM1-dependent mechanism.

Maegen A Ackermann, Jennifer M Petrosino, Heather R Manring, Patrick Wright, Vikram Shettigar, Ahmet Kilic, Paul M L Janssen, Mark T Ziolo, Federica Accornero

Abstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Maegen A AckermannDepartment of Physiology & Cell Biology, Dorothy M. Davis Heart & Lung Research Institute, Columbus, OH, USA. Electronic address: maegen.ackermann@osumc.edu.
Jennifer M PetrosinoDepartment of Physiology & Cell Biology, Dorothy M. Davis Heart & Lung Research Institute, Columbus, OH, USA.
Heather R ManringDepartment of Physiology & Cell Biology, Dorothy M. Davis Heart & Lung Research Institute, Columbus, OH, USA.
Patrick WrightDepartment of Physiology & Cell Biology, Dorothy M. Davis Heart & Lung Research Institute, Columbus, OH, USA.
Vikram ShettigarDepartment of Physiology & Cell Biology, Dorothy M. Davis Heart & Lung Research Institute, Columbus, OH, USA.
Ahmet KilicDepartment of Surgery, The Ohio State University, Wexner Medical Center, Columbus, OH, USA.
Paul M L JanssenDepartment of Physiology & Cell Biology, Dorothy M. Davis Heart & Lung Research Institute, Columbus, OH, USA.
Mark T ZioloDepartment of Physiology & Cell Biology, Dorothy M. Davis Heart & Lung Research Institute, Columbus, OH, USA.
Federica AccorneroDepartment of Physiology & Cell Biology, Dorothy M. Davis Heart & Lung Research Institute, Columbus, OH, USA. Electronic address: federica.accornero@osumc.edu.
Lung Institute · USThe Ohio State University Wexner Medical Center · US

Funding

Post-transcriptional regulation of cardiac hypertrophyR01HL136951 · NHLBI · OHIO STATE UNIVERSITY · PI Federica Accornero · 2017 to 2026
$4.7M
Frequency-dependent modulation of cardiac myofilament function in health/diseaseR01HL113084 · NHLBI · OHIO STATE UNIVERSITY · PI JANSSEN, PAULUS ML · 2012 to 2023
$4.6M
Integrative Training in Biomedical SystemsT32GM068412 · NIGMS · OHIO STATE UNIVERSITY · PI PARVIN, JEFFREY D · 2005 to 2020
$2.4M
Novel Locations; Familiar Functions: Obscurin at the Cardiac Intercalated DiscR00HL116778 · NHLBI · OHIO STATE UNIVERSITY · PI BORZOK, MAEGEN A. · 2016 to 2018
$729k
BEX1 and the control of protein translation in cardiac hypertrophyR00HL121284 · NHLBI · OHIO STATE UNIVERSITY · PI ACCORNERO, FEDERICA · 2016 to 2018
$727k
NHLBI NIH HHS R00 HL116778NHLBI NIH HHS R00 HL121284NHLBI NIH HHS R01 HL113084NHLBI NIH HHS R01 HL136951NIGMS NIH HHS T32 GM068412
6 · The paper itself

Abstract

The contractile property of the myocardium is maintained by cell-cell junctions enabling cardiomyocytes to work as a syncytium. Alterations in cell-cell junctions are observed in heart failure, a disease characterized by the activation of Transforming Growth Factor beta 1 (TGFβ1). While TGFβ1 has been implicated in diverse biologic responses, its molecular function in controlling cell-cell adhesion in the heart has never been investigated. Cardiac-specific transgenic mice expressing active TGFβ1 were generated to model the observed increase in activity in the failing heart. Activation of TGFβ1 in the heart was sufficient to drive ventricular dysfunction. To begin to understand the function of this important molecule we undertook an extensive structural analysis of the myocardium by electron microscopy and immunostaining. This approach revealed that TGFβ1 alters intercalated disc structures and cell-cell adhesion in ventricular myocytes. Mechanistically, we found that TGFβ1 induces the expression of neural adhesion molecule 1 (NCAM1) in cardiomyocytes in a p38-dependent pathway, and that selective targeting of NCAM1 was sufficient to rescue the cell adhesion defect observed when cardiomyocytes were treated with TGFβ1. Importantly, NCAM1 was upregulated in human heart samples from ischemic and non-ischemic cardiomyopathy patients and NCAM1 protein levels correlated with the degree of TGFβ1 activity in the human cardiac ventricle. Overall, we found that TGFβ1 is deleterious to the heart by regulating the adhesion properties of cardiomyocytes in an NCAM1-dependent mechanism. Our results suggest that inhibiting NCAM1 would be cardioprotective, counteract the pathological action of TGFβ1 and reduce heart failure severity.

Indexed as

AnimalsCD56 AntigenCell AdhesionElectrocardiographyFemaleHeart FailureHumansMaleMice, TransgenicMyocardiumMyocytes, CardiacRatsTransforming Growth Factor beta1Ventricular DysfunctionCD56 AntigenNCAM1 protein, humanNcam1 protein, mouseTransforming Growth Factor beta1Cell adhesionHeart failureIntercalated discNCAM1TGFβ1

Identifiers

PMID28870505
PMCPMC5647243
OpenAlexW2750812653

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.